RXFP1 and asthma: First, a decrease in RXFP1 gene expression may weaken the anti-inflammatory effects of relaxin.[15] Relaxin is able to inhibit the activity of a variety of inflammatory cells, such as eosinophils, lymphocytes, and mast cells, which play a key role in the inflammatory response to asthma.